Failures in human extravillous trophoblast (EVT) development could be involved in the pathogenesis of pregnancy diseases. However, the underlying mechanisms have been poorly characterized. Here, we provide evidence that Notch signaling could represent a key regulatory pathway controlling trophoblast proliferation, motility, and differentiation. Immunofluorescence of first-trimester placental tissues revealed expression of Notch receptors (Notch2 and Notch3) and membrane-anchored ligands (delta-like ligand [DLL] 1 and -4 and Jagged [JAG] 1 and -2) in villous cytotrophoblasts (vCTBs), cell column trophoblasts (CCTs), and EVTs. Notch4 and Notch1 were exclusively expressed in vCTBs and in CCTs, respectively. Both proteins decreased in Western blot analyses of first-trimester, primary cytotrophoblasts (CTBs) differentiating on fibronectin. Luciferase reporter analyses suggested basal, canonical Notch activity in SGHPL-5 cells and primary cells that was increased upon seeding on DLL4-coated dishes and diminished in the presence of the Notch/γ-secretase inhibitors N-[N-(3,5-difluorophenacetyl-l-alanyl)]-S-phenylglycine t-butyl ester (DAPT) or L-685,458. Bromodeoxyuridine labeling, cyclin D1 mRNA expression, and cell counting indicated that chemical inhibition of Notch signaling elevated proliferation in the different primary trophoblast model systems. Notch inhibition also increased motility of SGHPL-5 cells through uncoated and fibronectin-coated Transwells, motility of primary CTBs, as well as migration in villous explant cultures on collagen I. Accordingly, small interfering RNA-mediated gene silencing of Notch1 also elevated SGHPL-5 cell migration. In contrast, motility of primary cultures and SGHPL-5 cells was diminished in the presence of DLL4. Moreover, DAPT increased markers of differentiated EVT, ie, human leukocyte antigen G1, integrin α5, and T-cell factor 4, whereas DLL4 provoked the opposite. In summary, the data suggest that canonical Notch signaling impairs motility and differentiation of first-trimester CTBs.
Pubmed ID: 24189144 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets HLA G
View all literature mentionsThis monoclonal targets cells that have bromodeoxyuridine incorporated in their DNA
View all literature mentionsThis monoclonal targets Integrin alpha 5 antibody [10F6]
View all literature mentionsThis monoclonal targets Notch1 (D6F11) XP Rabbit mAb
View all literature mentionsThis recombinant monoclonal targets Notch2
View all literature mentionsThis monoclonal targets Mouse to HLA-G
View all literature mentionsThis polyclonal targets Notch 2 antibody
View all literature mentionsThis monoclonal targets Mouse Cytokeratin 18 M30 CytoDEATH Clone M30
View all literature mentionsThis monoclonal targets Histone H3 (96C10) Mouse mAb (IHC Formulated)
View all literature mentionsThis polyclonal targets EGFR
View all literature mentionsThis polyclonal targets Vimentin
View all literature mentionsThis monoclonal targets ND
View all literature mentionsThis monoclonal targets OTN 11, ovarian carcinoma cell line (1, 8).
View all literature mentionsThis polyclonal targets NOTCH3
View all literature mentionsThis polyclonal targets SPINT1
View all literature mentionsThis monoclonal targets Phospho-Akt (Thr308) (C31E5E) Rabbit mAb
View all literature mentionsThis polyclonal targets DLL3
View all literature mentionsThis polyclonal targets Notch3
View all literature mentionsThis polyclonal targets p44/42 MAPK (Erk1/2)
View all literature mentionsThis polyclonal targets Cytokeratin, wide spectrum
View all literature mentionsThis polyclonal targets DLL4
View all literature mentionsThis recombinant monoclonal targets GAPDH
View all literature mentionsThis monoclonal targets EGFR (R-1)
View all literature mentionsThis polyclonal targets EGFR
View all literature mentionsThis unknown targets raised against amino acids 1779-2003 of Notch 4 of human origin.
View all literature mentionsThis monoclonal targets Jagged2
View all literature mentionsThis monoclonal targets Ki-67 clone Ki-S5
View all literature mentions